OR | 95% CI | P | OR | 95% CI | P | |
---|---|---|---|---|---|---|
Male | 2.31 | 0.77–6.96 | 0.13 | |||
Postoperative usage of somatostatin | 0.33 | 0.11–0.99 | 0.04 | 0.30 | 0.09–0.95 | 0.04 |
Age | 0.98 | 0.95–1.02 | 0.33 | |||
BMI | 1.02 | 0.73–1.43 | 0.91 | |||
Anatomy of fistula | ||||||
Stump | Ref | |||||
Bulb or descending portion | 2.11 | 0.68–6.53 | 0.19 | |||
Pars horizontalis duodeni | 4.80 | 0.69–33.11 | 0.11 | |||
Etiology | ||||||
Upper gastrointestinal tract tumor | Ref | Ref | ||||
Trauma | 1.53 | 0.38–6.06 | 0.55 | 1.49 | 0.37–6.05 | 0.57 |
Pancreatitis | 4.62 | 0.99–21.34 | 0.05 | 5.05 | 1.05–24.36 | 0.04 |
High output | 0.54 | 1.95–1.52 | 0.24 | |||
Combined with abdominal hernia | 0.80 | 0.36–1.81 | 0.59 | |||
Preoperative hemoglobin | ||||||
≥ 120 g/L | Ref | |||||
> 100 g/L, and < 120 g/L | 1.29 | 0.47–3.56 | 0.62 | |||
Preoperative albumin | ||||||
≥ 35 g/L | Ref | |||||
> 30 g/L, and < 35 g/L | 0.48 | 0.33–1.19 | 0.17 | |||
Glutamic pyruvic transaminase | ||||||
Creatinine | ||||||
Blood loss | ||||||
< 1000 mL | Ref | |||||
≥ 1000 mL | 1.27 | 0.47–3.45 | 0.64 | |||
Glutamic pyruvic transaminase | 1.05 | 0.74–1.18 | 0.72 | |||
Total bilirubin | 0.96 | 0.52–1.39 | 0.49 | |||
Creatinine | 0.99 | 0.61—1.24 | 0.67 | |||
Duration of definitive surgery | ||||||
< 4 h | Ref | |||||
≥ 4 h | 1.65 | 0.61—4.52 | 0.33 | |||
Surgical procedure | ||||||
Suture | Ref | |||||
Duodenojejunostomy Roux-en-Y | 1.05 | 0.361—3.03 | 0.94 | |||
Required blood transfusion within 48 h after definitive surgery | ||||||
< 1000 mL | Ref | |||||
≥ 1000 mL | 1.76 | 0.64—4.82 | 0.27 | |||
Required albumin transfusion within 48 h after definitive surgery | ||||||
< 100 g | Ref | |||||
≥ 100 g | 1.91 | 0.69—5.33 | 0.22 | |||
Hypertension | 5.94 | 0.35—99.58 | 0.22 | |||
Diabetes mellitus | 2.00 | 0.37—10.79 | 0.42 |